Company leaders have a role to play in the worldwide vaccination effort.
The availability of coronavirus vaccines in some countries could mean the beginning of the end of the acute pandemic. Now leaders face pressing questions about how quickly and successfully vaccinations can reach scale and how organizations can contribute to the effectiveness of the vaccine rollout. During a McKinsey Live webinar, partners Tania Holt and Adam Sabow addressed six pressing questions related to vaccine delivery and adoption:
- What’s the latest on vaccine development?
- What are the implications of the new virus strains?
- How is the rollout expected to work?
- How is it going so far?
- When will the pandemic end?
- What role can companies play?
For more on this topic, please watch the webinar recording and read the articles “When will the COVID-19 pandemic end?,” “COVID-19 Consumer Healthcare Insights: What 2021 may hold,” “The COVID-19 vaccines are here: What comes next?,” and “COVID-19 vaccines meet 100 million uncertain Americans.”
Disclaimer: This webinar was intended to provide insight on currently available information and does not constitute legal, medical, policy or other regulated advice.
The contents of this site, including any statements, articles, graphics, charts, checklists, and other materials (“Content”) are for informational purposes only. The Content is not intended to be a substitute for professional advice or constitute medical advice.
This content was previously posted on McKinsey’s COVID Response Center and is subject to our commitment to the Open Covid Pledge under these Terms of Use.